RARA CRAFT DATABASE for FDA Medical Devices
510(k)K253992

FDA DEVICE FACTS

Veritas Reverse Total Shoulder System

Restor3D

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

AI/ML
DECISION DATEMay 7, 2026PRODUCT CODEPHX

Indications for use

The Veritas Reverse Total Shoulder System is indicated for use in patients whose shoulder joint has a grossly deficient rotator cuff with severe arthropathy and/or previously failed shoulder joint replacement with a grossly deficient rotator cuff. The patient must be anatomically and structurally suited to receive the implants, and a functional deltoid muscle is necessary. The Veritas Reverse Total Shoulder System standard components are indicated for primary, fracture and revision total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency. The system's patient-specific components are only indicated for primary total shoulder replacement. Glenoid components with porous surface are indicated for uncemented application with the addition of screw fixation. Humeral components with porous surface are indicated for either cemented or uncemented applications. Note: A CT scan is used to create the Veritas patient-specific components.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026